SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is surging alongside the broader crypto market following news of a two-week ceasefire between the U.S. and Iran, which has sparked optimism over the stabilization of global trade and energy supply lines. The community is actively discussing the potential for a sustained breakout, with many traders closely monitoring institutional inflows and technical resistance levels to determine if the rally can maintain momentum.

Maulcoin

Maulcoin is trending as a community-driven project that is gaining traction through active social engagement and plans for upcoming airdrops as it hits key market capitalization milestones. Supporters are rallying around the brand's 'dark side' theme, framing it as a long-term, rug-proof alternative to traditional meme coins while anticipating a breakout as it works toward wider visibility and chart integration.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is currently capturing community attention as a legacy meme project that draws parallels to Bitcoin's early skeptical reception while positioning itself as a satirical store of value. Investors are actively debating its potential for long-term growth, with proponents emphasizing the project's historical roots and its narrative as a community-driven movement that aims to challenge conventional financial norms.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following a significant earnings miss and a cautious debut from new CEO Greg Abel, sparking intense debate among shareholders about the company's long-term capital allocation strategy. While some investors view the recent price drop as a generational buying opportunity for a cash-rich fortress, others are aggressively criticizing the firm as dead money for refusing to pivot into higher-growth tech sectors or provide a dividend.

$LADYS coin has no association with Charlotte Fang or her creation Milady Maker. This token is simply paying homage to a meme we all love and recognize.  $LADYS is a meme coin with no intrinsic value or expectation of financial return. There is no formal team or roadmap. the coin is completely useless and for entertainment purposes only.  The project was initiated on 05 May 2023 and the contract was deployed on 07 May 2023.  The project will be launching a dapp on the official website for all holders of PEPE tokens and Milady Maker NFTs to claim $LADYS.

Milady

The community is actively discussing the potential for a major meme coin cycle and exchange listings, with many holders focused on dollar-cost averaging in anticipation of a broader market supercycle. Conversations are heavily polarized, with optimistic supporters touting long-term growth and potential for massive returns, while skeptics frequently label the project as a struggling or stagnant asset.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is gaining strong momentum driven by anticipation surrounding its upcoming cross-chain expansion and a strategic merger, with the community closely tracking its role as the central liquidity hub within the Base ecosystem. Investors are highlighting its robust fee generation and active supply reduction models as key indicators of long-term utility, fueling bullish sentiment despite recent market volatility.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. (ALOY) is trending due to the company's strategic positioning as a domestic rare earth processing and magnet production firm, a move supported by defense-sector board appointments and recent supply chain agreements. The community is actively debating the company's growth potential against the backdrop of 2027 U.S. defense procurement mandates, with discussions split between optimism over its defense-industrial mission and skepticism regarding its pre-revenue status and capital structure.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently facing intense community debate regarding its lack of significant price action compared to the broader market, with many participants actively discussing potential upcoming business developments and strategic news anticipated for 2026. While some investors remain committed to long-term accumulation, others are voicing frustration over prolonged stagnation and the project's perceived lag behind Bitcoin and emerging niche tokens.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a community-driven project that aims to bridge global cannabis culture with Web3, attracting long-term holders focused on organic growth and advocacy. Investors are actively discussing its potential ahead of upcoming cannabis-related milestones, while sentiment remains centered on the token's identity as a 'culture-first' alternative to traditional speculative memes.

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita is seeing significant market activity as investors weigh the long-term impact of GLP-1 weight-loss drugs on the dialysis sector, leading to heightened volatility and concerns about future patient growth. The community is actively debating whether the recent sell-off represents an overreaction to medical trial news or a fundamental shift in the kidney care landscape that warrants a defensive posture.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

bioAffinity Technologies CyPath Lung to Be Featured at Cleveland Clinic Annual Advances in Early Lung Cancer Detection Symposium April 16

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, announces that its CyPath Lung test will be featured at...

<ul class="summary-bullets"><li>CyPath uses flow cytometry and AI to provide “likely” or “unlikely” malignancy results.</li><li>Rising pulmonary nodules and lung cancer survivors could drive market revenue to over $560 million.</li><li>bioAffinity’s commercial initiatives include expanding physician sites, peer education, and integration into clinical workflows.</li></ul>bioAffinity Technologies, Inc. (BIAF) announced on Wednesday that its CyPath Lung test has surpassed sales expectations in the first quarter of 2026, recording a 146% year-over-year increase in unit sales.CyPath Lung combines flow cytometry with AI to deliver clear “likely” or “unlikely” malignancy results to physicians. Real-world applications suggest the test can detect lung cancer at Stage 1A, improving treatment outcomes, and reduce unnecessary invasive procedures when malignancy risk is low.<h2 class="st-heading-2">Strong Market Demand</h2>Estimates from the U.S. Preventive Services Task Force suggest that indeterminate pulmonary nodules detected in the U.S. will increase 62%, from 2.9 million in 2025 to 4.7 million by 2030. The number of lung cancer survivors is also expected to rise from 680,000 to more than 871,000 over the same period.&nbsp;Capturing just 10% of these markets could generate $358 million in revenue for CyPath Lung, growing to over $560 million in five years, driven by a 10% compound annual growth rate fueled by broader screening adoption and AI-enhanced imaging technologies.<blockquote>“CyPath Lung is designed to address a critical gap in the diagnostic pathway by supporting lung cancer risk assessment, pulmonary nodule management and post-treatment surveillance.”-Maria Zannes, President and CEO of bioAffinity Technologies</blockquote>Following the update, bioAffinity stock traded over 8% higher in Wednesday’s premarket.&nbsp;On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory while message volume shifted to ‘low’ from ‘normal’ levels in 24 hours.&nbsp;<h2 class="st-heading-2">Commercial Strategy Boosts Adoption</h2>bioAffinity has focused on CyPath Lung as its flagship product, expanding ordering sites, promoting peer-to-peer education among pulmonologists, and integrating the test into routine lung cancer risk assessment workflows.&nbsp;Revenue for CyPath Lung rose 87% year-over-year in 2025, while test units sold grew 99% compared to 2024.BIAF stock has gained over 260% year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/msft-stock-struggles-weakest-magnificent-seven-in-q1-and-now-it-is-spending-5-5-b-more-on-ai/cZ7HZG9RInw">MSFT Stock Struggles As Weakest Of Magnificent Seven In Q1 – And Now It Is Spending $5.5B More On AI</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the BioAffinity Technologies logo is displayed on the screen of a tablet.

BIAF Stock Gains As CyPath Sales Surge 146% In Q1

bioAffinity Technologies, Inc. (BIAF) announced on Wednesday that its CyPath Lung test has surpassed sales expectations in the first quarter of 2026, recording a 146% year-over-year increase in unit sales.

Equity

The test is capable of identifying lung cancer at Stage 1A, enhancing chances for effective treatment.


bioAffinity Technologies CyPath Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit sales for its CyPath Lung...

<ul class="summary-bullets"><li>Urban-Gro’s merger with Flash Sports and Media marked a notable transition beyond indoor agriculture into sports-focused media.</li><li>Turbo Energy benefited from escalating tensions in the Middle East that sent energy prices higher.</li><li>bioAffinity reported strong sales growth for its lung diagnostic product, CyPath, and ambitious 100% growth guidance in 2026.</li></ul>A handful of lesser-known companies stole the spotlight in March, surging ahead of the broader market amid decisive operational shifts and real-world execution.Urban-gro, Inc. (UGRO), Turbo Energy S.A. (TURB), AleAnna, Inc. (ANNA), EpicQuest Education Group International (EEIQ), and bioAffinity Technologies, Inc. (BIAF) posted triple-digit percent gains during the month.<h2 class="st-heading-2">Shift Toward Execution Over Hype</h2>While large-cap technology names struggled amid sector rotation, these smaller firms capitalized on geopolitical disruptions, internal restructuring, and performance milestones to deliver outsized gains.Urban-Gro staged a sharp recovery after regaining compliance with Nasdaq listing standards in early March. The removal of delisting concerns lifted investor confidence. At the same time, its merger with Flash Sports and Media marked a notable transition beyond indoor agriculture into sports-focused media and marketing, reshaping its growth narrative.<a href="https://stocktwits.com/symbol/UGRO">Urban-Gro stock</a> traded over 4% higher in Tuesday’s premarket and has surged over 731% in March.&nbsp;<h2 class="st-heading-2">Shielding From Energy Shocks And The European LNG Supply Crisis</h2>Turbo Energy benefited from escalating tensions in the Middle East that sent energy prices higher. Its AI-powered energy storage systems gained traction among European industrial clients seeking to stabilize operating costs. On March 6, the company disclosed a $53 million backlog in industrial orders, further reinforcing optimism around its standing in the energy security space.&nbsp;<a href="https://stocktwits.com/symbol/TURB">Turbo Energy stock</a> traded over 6% lower in Tuesday’s premarket and has posted a gain of over 314% in March.&nbsp;&nbsp;AleAnna surged as supply shocks rattled global liquefied natural gas markets. Disruptions tied to the Middle East conflict tightened availability, elevating the strategic importance of the company’s Italian gas assets.&nbsp;On March 12, the company announced significant increases to its proved reserves across key Po Valley fields, following the completion of its final 2025 reserves report.&nbsp;<a href="https://stocktwits.com/symbol/ANNA">AleAnna stock</a> traded over 2% higher in Tuesday’s premarket, with over 25% gains in March.&nbsp;<h2 class="st-heading-2">Low Float And Growth Milestones&nbsp;</h2>After completing a 1-for-16 reverse stock split in late February, EpicQuest Education Group began March with a reduced float of about 1.48 million shares, allowing for extreme price velocity on relatively low buying volume.<a href="https://stocktwits.com/symbol/EEIQ">EpicQuest stock</a> has surged by over 242% in March.&nbsp;Meanwhile bioAffinity Technologies delivered one of the most dramatic moves, nearly doubling in a single trading session on March 13. Strong sales growth for its lung diagnostic product, CyPath, and ambitious 100% growth guidance in 2026, suggested the company had successfully transitioned from the development stage to revenue-generating operations.<a href="https://stocktwits.com/symbol/BIAF">BIAF stock</a> has increased by over 233% in March.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-red-cat-holding-stock-up-premarket/cZEPrK6RIVP">Why Is RCAT Stock Rising Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

UGRO, TURB, ANNA, EEIQ, BIAF: These Five Stocks Outpaced Big Tech With Massive March Returns

As big tech faltered during sector shifts, share prices of some of the smaller companies surged amid restructuring efforts and key business achievements.

What's Going On With bioAffinity Technologies Stock Wednesday?

bioAffinity Technologies Inc (NASDAQ: BIAF) shares trade higher in Wednesday's premarket after announcing a live virtual roundtable for its CyPath Lung test.read more...

bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath Lung into Pulmonary Practice

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced it will host the first of a series of live...

BIAF Stock Surges 85%, Breaks 200-DMA For The First Time In Nearly A Year – Here’s What’s Driving The Rally

The stock has been on a sharp uptrend, gaining more than 160% over the past week on the back of bullish CyPath Lung estimates.

Promising Biotech Stocks To Consider - March 23rd

Apogee Therapeutics, Danaher, bioAffinity Technologies, ImmunityBio, argenex, Moderna, and Vertex Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies whose primary business is developing b...

Top Biotech Stocks To Follow Today - March 17th

Vertex Pharmaceuticals, bioAffinity Technologies, Lunai Bioworks, Danaher, Moderna, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Small Caps Surge on Breakouts, Biotech Validation, and “Real-World” Tech Adoption

Momentum is building across small-cap names this week, with a mix of technical breakouts, clinical validation, and commercialization milestones driving a more constructive tone beneath the surface of the market. $LNAI, $BIAF, $IBRX, $KBLB, $UCAR, $LIDR, $JTAI, $FLYX

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$2.70	$5.98	321.48%	BEAT
Q3 '25	-$2.70	-$4.74	-75.56%	MISSED
Q2 '25	-$0.10	-$5.10	-5000.00%	MISSED
Q1 '25	-$0.16	-$0.16	--	EXPECTED
Q4 '24	-$0.14	-$0.19	-35.71%	MISSED

BIAF
BioAffinity Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest BIAF News

BIAFBioAffinity Technologies Inc